First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome

Findings spotlighted in oral presentation at the 5th annual World Congress of Cutaneous Lymphomas meeting in Pasadena, CA TOKYO–(BUSINESS WIRE)–On Friday, 12th April, 2024, Professor Julia Scarisbrick of University of Birmingham presented interim findings from the Kyowa Kirin, Inc. (Kyowa Kirin, TSA: 4151)-sponsored study, “Real-World Observational Study of Mogamulizumab in Adult Patients with Mycosis Fungoides … [Read more…]

Elevance Health and Clayton, Dubilier & Rice Sign Agreement to Launch Strategic Partnership to Advance Primary Care Delivery

Collaboration will leverage the strengths of three care provider entities that will come together to deliver value to consumers and employers across the healthcare journey INDIANAPOLIS–(BUSINESS WIRE)–Elevance Health, Inc. (NYSE: ELV) and Clayton, Dubilier & Rice (CD&R) announced an agreement to form a strategic partnership to accelerate innovation in primary care delivery, enhance the healthcare … [Read more…]

Pacific Prime Affirmed as the Top Individual Producer of Allianz for Four Consecutive Years

DUBAI, United Arab Emirates–(BUSINESS WIRE)–International insurance brokerage Pacific Prime was awarded the Top Individual Producer Award 2024 by Allianz. On the 18th of March, the Allianz team visited Pacific Prime’s office in Dubai to present the award to acknowledge their exceptional performance in offering international health insurance solutions to individual clients worldwide. The award represents … [Read more…]

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) will hold its Annual General Meeting of Shareholders (“AGM”) at 10:30 a.m. CEST on May 23, 2024 in its headquarters, 117 avenue de Luminy, F-13009 Marseille. The Notice of Meeting of this AGM was published on April 15, 2024 … [Read more…]

Global Research Antibodies & Reagents Market Outlook & Forecasts, 2023 and 2024-2029: Growing Demand for Precision Medicine, Rising Focus on Biomarker Discovery, & Rise in Proteomics and Genomics –

DUBLIN–(BUSINESS WIRE)–The “Global Research Antibodies & Reagents Market – Outlook & Forecast 2024-2029” report has been added to’s offering. The Global Research Antibodies & Reagents Market was valued at USD 13.39 billion in 2023, and is projected to reach USD 21.28 billion by 2029, showcasing a CAGR of 8.03% The global research antibodies & … [Read more…]

Interim HealthCare Inc. Wins Aspect Marketing & Advertising Award in Video Category

Campaign video features once-in-a-lifetime fishing experience for a veteran benefiting from hospice and palliative care SUNRISE, Fla.–(BUSINESS WIRE)–Interim HealthCare Inc., the nation’s leading network of home care, senior care, home health, hospice and medical staffing services, has won an Aspect Marketing & Advertising Award in the video or television campaign category for its entry, “Making … [Read more…]

Global Automated Sample Preparation for Genomic Applications Research Report 2024: Increasing Opportunity for Automated Systems in Developing Countries – Forecasts to 2033 –

DUBLIN–(BUSINESS WIRE)–The “Automated Sample Preparation (For Genomic Applications) – A Global and Regional Analysis: Focus on Product, Application, End-User, and Region” report has been added to’s offering. The global automated sample preparation market was valued at $1,431.9 million in 2023 and is expected to reach $3,730.5 million by 2033, growing at a CAGR of … [Read more…]

Modalis Announces Partnership with Ginkgo Bioworks

Modalis Joins Ginkgo’s Technology Network TOKYO & WALTHAM, Mass.–(BUSINESS WIRE)–Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announced that it has entered into an agreement with Ginkgo Bioworks (Ginkgo) to join the Ginkgo Technology Network. This strategic alliance will enable Ginkgo’s global customers in the cell and gene therapy fields to access Modalis’ proprietary epigenome … [Read more…]

Moderna Betrays Africa, Says AHF

LOS ANGELES–(BUSINESS WIRE)–#Africa—AIDS Healthcare Foundation (AHF) says Moderna’s promise to build a state-of-the-art mRNA manufacturing facility in Africa in 2022 was nothing more than a self-serving effort to deflect criticism for price gouging on its COVID-19 vaccine after the pharma company announced today that it’s suspending the project. “Moderna’s greed knows no bounds. It raked … [Read more…]

Aptar Declares Quarterly Dividend

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is May 16, 2024, to stockholders of record as of April 25, 2024. As previously announced, Aptar will hold a conference call … [Read more…]